COGENTIN Solution for injection Ref.[9977] Active ingredients: Benzatropine

Source: FDA, National Drug Code (US)  Revision Year: 2020 

Product description

Benztropine mesylate is a synthetic compound containing structural features found in atropine and diphenhydramine.

It is designated chemically as 8-azabicyclo[3.2.1] octane, 3-(diphenylmethoxy)-,endo, methanesul-fonate. Its empirical formula is C21H25NO•CH4O3S, and its structural formula is:

Benztropine mesylate is a crystalline white powder, very soluble in water, and has a molecular weight of 403.54.

COGENTIN (benztropine mesylate) is supplied as a sterile injection for intravenous and intramuscular use.

Each milliliter of the injection contains:

Benztropine mesylate 1 mg
Sodium chloride 9 mg
Water for injection q.s 1 mL

Actions

COGENTIN possesses both anticholinergic and antihistaminic effects, although only the former have been established as therapeutically significant in the management of parkinsonism.

In the isolated guinea pig ileum, the anticholinergic activity of this drug is about equal to that of atropine; however, when administered orally to unanesthetized cats, it is only about half as active as atropine.

In laboratory animals, its antihistaminic activity and duration of action approach those of pyrilamine maleate.

How Supplied

Injection COGENTIN, 1 mg per mL, is a clear, colorless solution and is supplied as follows:

NDC 76478-611-02 in boxes of 5 × 2 mL ampuls.

AKORN:

Distributed by: Akorn, Inc., Lake Forest, IL 60045

OAK:

Mfd. for: Oak Pharmaceuticals, Inc.

Drugs

Drug Countries
COGENTIN Singapore, United States

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.